/ Published in 2010, Publication

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, Jentsch U, Pool R, Chisembele M, Kapiga S, Mutemwa R, Vallely A, Palanee T, Sookrajh Y, Lacey CJ, Darbyshire J, Grosskurth H, Profy A, Nunn A, Hayes R, Weber J.
Lancet. 2010 Oct 16;376(9749):1329-37. Epub 2010 Sep 17.
PMID: 20851460
Related citation

What you can read next

Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa
Development of a curriculum to educate religious leaders about blood pressure using community-based participatory research and educational theory in Mwanza, Tanzania.
HIV vaccines: current status worldwide and in Africa.

You must be logged in to post a comment.